|
|
Article: First Antibiotic in New Class of Drugs Fights Resistant Infections.(antibacterial drug Zyvox approved by the FDA)(Brief Article)
- Article from:
- FDA Consumer
- Article date:
- July 1, 2000
CopyrightCOPYRIGHT 2000 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
The first in a new class of antibacterial drugs to treat serious infections resistant to other antibiotics has been approved by the Food and Drug Administration. Zyvox (linezolid) was approved April 18, less than a month after an FDA advisory committee reviewed study data and recommended its approval.
Zyvox treats infections, including bloodstream infections, associated with vancomycin-resistant Enterococcus faecium (VREF). Vancomycin has long been the drug of last resort in treating infections resistant to other antibiotics. Zyvox also was approved for the treatment of hospital-acquired pneumonia and complicated skin infections, including those due to ...